Knight Therapeutics Stock Forecast - Naive Prediction

GUD Stock  CAD 5.48  0.02  0.37%   
The Naive Prediction forecasted value of Knight Therapeutics on the next trading day is expected to be 5.52 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.86. Knight Stock Forecast is based on your current time horizon. Although Knight Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Knight Therapeutics' systematic risk associated with finding meaningful patterns of Knight Therapeutics fundamentals over time.
  
At this time, Knight Therapeutics' Payables Turnover is very stable compared to the past year. As of the 26th of June 2024, Receivables Turnover is likely to grow to 3.51, while Inventory Turnover is likely to drop 1.22. . As of the 26th of June 2024, Common Stock Shares Outstanding is likely to grow to about 123.2 M, though Net Loss is likely to grow to (25.6 M).
Most investors in Knight Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Knight Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Knight Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
A naive forecasting model for Knight Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Knight Therapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Knight Therapeutics Naive Prediction Price Forecast For the 27th of June

Given 90 days horizon, the Naive Prediction forecasted value of Knight Therapeutics on the next trading day is expected to be 5.52 with a mean absolute deviation of 0.06, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.86.
Please note that although there have been many attempts to predict Knight Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Knight Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Knight Therapeutics Stock Forecast Pattern

Backtest Knight TherapeuticsKnight Therapeutics Price PredictionBuy or Sell Advice 

Knight Therapeutics Forecasted Value

In the context of forecasting Knight Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Knight Therapeutics' downside and upside margins for the forecasting period are 3.92 and 7.11, respectively. We have considered Knight Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
5.48
5.52
Expected Value
7.11
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Knight Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Knight Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria113.098
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0633
MAPEMean absolute percentage error0.0109
SAESum of the absolute errors3.863
This model is not at all useful as a medium-long range forecasting tool of Knight Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Knight Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Knight Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Knight Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Knight Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
3.875.477.07
Details
Intrinsic
Valuation
LowRealHigh
3.104.706.30
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.020.06
Details

Other Forecasting Options for Knight Therapeutics

For every potential investor in Knight, whether a beginner or expert, Knight Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Knight Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Knight. Basic forecasting techniques help filter out the noise by identifying Knight Therapeutics' price trends.

Knight Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Knight Therapeutics stock to make a market-neutral strategy. Peer analysis of Knight Therapeutics could also be used in its relative valuation, which is a method of valuing Knight Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Knight Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Knight Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Knight Therapeutics' current price.

Knight Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Knight Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Knight Therapeutics shares will generate the highest return on investment. By undertsting and applying Knight Therapeutics stock market strength indicators, traders can identify Knight Therapeutics entry and exit signals to maximize returns.

Knight Therapeutics Risk Indicators

The analysis of Knight Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Knight Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting knight stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Knight Stock

Knight Therapeutics financial ratios help investors to determine whether Knight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Knight with respect to the benefits of owning Knight Therapeutics security.